Based on these findings, some endogenous immunomodulators, such as peroxisome proliferator-activated receptors (PPARγ), PPARγ coactivator-1alpha (PGC-1α), and some metabolites of the KP, were explored as modulator molecules in MS. The gene discussed is PPARGC1A; the disease is myeloid sarcoma.